Jonathan Synett

According to Synett, NCL Technology Ventures “are at the forefront of a radical change in new medical technologies and therapeutics, from robotics to revolutionary cancer treatments. These advances will benefit millions of people and we’re looking to invest in start-ups and SMEs so they can scale up and reach the NHS and other markets with their cutting-edge innovations.